Monograph
D11AX18 - Diclofenac |
Propably not porphyrinogenic |
PNP |
Rationale
Diclofenac (ATC code: D11A X18) for topical administration is safety classified as Probably not porphyrinogenic because of minimal systemic exposure and because diclofenac for systemic use (ATC code: M01A B05) is classified as Probably not porphyrinogenic (PNP).
For more details of the metabolism of diclofenac please refer to the monograph of diclofenac for systemic use (ATC code: M01A B05).
Metabolism and pharmacokinetics
Absorption after topical administration is < 1-12% (SPC).
IPNet drug reports
Uneventful use reported in 4 patients with acute porphyria.
Similar drugs
References
| # | Citation details | PMID |
|---|---|---|
| * | Summary of Product Characteristics | |
| 1. | Norwegian medicines agency. Summary of Product Characteristics (SPC). Solaraze.
|
|
Tradenames
This list comprises raw data collected from different countries.
In some cases, a more comprehensive list of available drug packages is included.
Consequently, very similar terms may therefore appear multiple times.
Bold names are the searchable terms, while the gray names that follow are all mapped to the bolded term.
Note: The cleaning is done automatically by a proprietary algorithm, and it may produce errors.
We strive to improve it continuously.
Diclofenaco Teva 30 mg/g gel · Solacutan 30 mg/g gel · SOLARAZE 30 mg/g GEL · Soliker 30 mg/g gel · Zorequin 30 mg/g gel 
Solacutan · Solaraze 
Solaraze 
Solaraze 
Medulan · Solacutan 
Diclofenac-ratiopharm · Solaraze 
Solaraze 3% 
Solaraze
© NAPOS 2025